This inventor holds 1 USPTO granted patent. Top assignee: The City University of New York. Active years: 1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981
Title: Thomas S Parker: Innovator in Cholesterol Biosynthesis Inhibition
Introduction
Thomas S Parker is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the area of cholesterol biosynthesis.
Latest Patents
Parker holds a patent for "In vivo inhibitors of cholesterol biosynthesis." This patent includes the compounds dialkyl esters of 5-carbo[etiocholane-3'.alpha.-7'.alpha., 12'.alpha.-trihydroxy-17'.beta.(1' methyl-4' butyl]oxy-4-hydroxy-4-methylpentyl-1-phosphonate and 5-carbohexadecyloxy-4-hydroxy-4-methylpentyl-1-phosphonate. These compounds have been shown to inhibit cholesterol biosynthesis in rat liver cells, and the preparation of the active compounds is detailed within the patent.
Career Highlights
Parker is affiliated with the City University of New York, where he continues to engage in research and innovation. His work has implications for understanding and potentially treating cholesterol-related health issues.
Collaborations
He has collaborated with notable colleagues, including Robert R Engel and Virender K Sarin, contributing to advancements in his field.
Conclusion
Thomas S Parker's work in cholesterol biosynthesis inhibition showcases his innovative spirit and dedication to scientific research. His contributions are valuable to the ongoing exploration of biochemistry and health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile